Skip to content

OnyxBiotech News

Subscribe About Onyx
Cell & Gene Leaders Live Sunday 15 November 2026 · The Shard (Shangri-La), London · One-day summit for cell & gene therapy leaders Sunday 15 November 2026 · The Shard (Shangri-La), London Get tickets → London Life Sciences Week Guide The unofficial London Life Sciences Week Guide, published by Onyx Newsroom · Every event 15–19 November 2026 Every event 15–19 November 2026 · Published by Onyx Newsroom Plan your week →
Live Interviews Editor's pick

Mike Exton, CEO, Lexicon Pharmaceuticals | JPM 2026

A clear message to investors: get in!

Dr. Adil Ali
Published
1 min read

📈 Stock

Lexicon Pharmaceuticals
NASDAQ: LXRX
Data and chart by TradingView.

At the end of Jan 2026, Mike Exton ran the Nasdaq Closing Bell to celebrate Lexicon Pharmaceuticals' 30th anniversary.

A recent positive end-of-Phase 2 meeting with the FDA now positions pilavapadin to advance into Phase 3 trials.

Please sign-up to continue reading

Subscribe

Be the first to receive exclusive interviews with cutting-edge biotech and pharma CEOs, straight to your inbox. Unsubscribe at any time. Already have an account? Sign In

Coming up: Cell & Gene Leaders Live, Sun 15 Nov at The Shard · London Life Sciences Week Guide, 15–19 Nov 2026 ·

More Live Interviews ↗